The National Institutes of Health has launched a research programme aimed at understanding the place of genomic sequencing in diagnosing diseases in newborn babies and improving their treatments.
The programme, worth £25 million over five years, will explore the potential of whole genome sequencing to identify diseases in newborn babies as well as ethical, legal and social implications and challenges for the possible use of the information.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.